epidepride has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozell, LB; Machida, CA; Neve, KA; Neve, RL | 1 |
| Cox, BA; Henningsen, RA; Neve, KA; Neve, RL; Spanoyannis, A | 1 |
2 other study(ies) available for epidepride and Glioma
| Article | Year |
|---|---|
Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Base Sequence; Benzamides; Benzazepines; Binding, Competitive; Cell Line; DNA Primers; Dopamine; Dopamine Agonists; Dopamine Antagonists; Glioma; Kinetics; Molecular Sequence Data; Polymerase Chain Reaction; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Fusion Proteins; Signal Transduction; Spiperone; Tumor Cells, Cultured | 1994 |
Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors.
Topics: Adenylyl Cyclase Inhibitors; Alanine; Animals; Base Sequence; Benzamides; Cell Line; Glioma; Immunoblotting; Iodine Radioisotopes; Ligands; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Pyrrolidines; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; RNA, Messenger; Serine; Tumor Cells, Cultured | 1992 |